Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Asset Utilization Ratio (2016 - 2025)

Integra Lifesciences Holdings' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.45 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 13.51% year-over-year to 0.45; the TTM value through Dec 2025 reached 0.45, up 13.51%, while the annual FY2025 figure was 0.43, 3.93% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.45 at Integra Lifesciences Holdings, roughly flat from 0.45 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.45 in Q4 2025 and bottomed at 0.38 in Q2 2024.
  • The 4-year median for Asset Utilization Ratio is 0.41 (2023), against an average of 0.41.
  • The largest annual shift saw Asset Utilization Ratio dropped 6.5% in 2024 before it grew 16.84% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.4 in 2022, then rose by 1.27% to 0.41 in 2023, then fell by 3.03% to 0.4 in 2024, then grew by 13.51% to 0.45 in 2025.
  • Per Business Quant, the three most recent readings for IART's Asset Utilization Ratio are 0.45 (Q4 2025), 0.45 (Q3 2025), and 0.42 (Q2 2025).